Display options
Cite
Chan TY. Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiol Drug Saf. 1996;5(1):53-4doi: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G.
Chan, T. Y. (1996). Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiology and drug safety, 5(1), 53-4. https://doi.org/10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G
Chan, T Y. "Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure." Pharmacoepidemiology and drug safety vol. 5,1 (1996): 53-4. doi: https://doi.org/10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G
Chan TY. Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiol Drug Saf. 1996 Jan;5(1):53-4. doi: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G. PMID: 15088278.
Copy Download .nbib Format: NLM
Share it on

Pharmacoepidemiol Drug Saf. 1996 Jan;5(1):53-4. doi: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G.

Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure.

Pharmacoepidemiology and drug safety

T Y Chan

PMID: 15088278 DOI: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G

[No abstract available.]

Publication Types